Fibrinogen Mumbai: Intracellular retention due to a novel G434D mutation in the Bβ-chain gene

Haematologica

Volumn 91, Issue 5, 2006, Pages 628-633

  Monaldini, Luca ^a   Asselta, Rosanna ^a   Duga, Stefano ^a   Peyvandi, Flora ^a   Ghosh, Kanjaksha ^b   Malcovati, Massimo ^a   Tenchini, Maria Luisa ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b KEM HOSPITAL   (India)

Author keywords

Congenital afibrinogenemia; Fibrinogen B chain; Hypofibrinogenemia; Missense mutation; Protein in vitro expression

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW CELL; CANCER CELL; CANCER CHEMOTHERAPY; CD34 SELECTION; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; DRUG MEGADOSE; FEASIBILITY STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUTROPHIL; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION; THROMBOCYTE; UNIVARIATE ANALYSIS;

ADULT; AFIBRINOGENEMIA; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CEREBRAL HEMORRHAGE; CONSANGUINITY; COS CELLS; EXONS; FATAL OUTCOME; FEMALE; FIBRINOGEN; FIBRINOGENS, ABNORMAL; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

EID: 33744471907     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Doolittle RF. Fibrinogen and fibrin. Annu Rev Biochem 1984;53:195-229.
2. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 2001;936:11-30.
3. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The Human Genome Browser at UCSC. Genome Res 2002;12:996-1006. http://genome.ucsc.edu/. Accessed September 1, 2005.
4. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
5. Redman CM, Xia H. Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion. Ann N Y Acad Sci 2001;936:480-95.
6. Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 1997;389:455-62.
7. Yang Z, Mochalkin I, Veerapandian L, Riley M, Doolittle RF. Crystal structure of native chicken fibrinogen at 5.5-A resolution. Proc Natl Acad Sci USA 2000;97:3907-12.
8. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243-52.
9. Mosesson MW. Fibrinogen gamma chain functions. J Thromb Haemost 2003;1:231-8.
10. Asselta R, Duga S, Spena S, Santagostmo E, Peyvandi F, Piseddu G, et al. Congenital aribrinogenemia: mutations leading to premature termination codons in fibrinogen Aa-chain gene are not associated with the decay of the mutant mRNAs. Blood 2001;98:3685-92.
11. Neerman-Arbez M. The molecular basis of inherited afibrinogenemia. Thromb Haemost 2001;86:154-63.
12. Asselta R, Spena S, Duga S, Peyvandi F, Malcovati M, et al. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bb-chain gene causing afibrinogenemia. Haematologica 2002;87:855-9.
13. Spena S, Duga S, Asselta R, Malcovati M, Peyvandi F, Tenchini ML. Con-genital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bb-chain gene causing activation of cryptic splice sites. Blood 2002;100:4478-84.
14. Vlietman JJ, Verhage J, Vos HL, van Wijk R, Remijn JA, van Solinge WW, et al. Congenital afibrinogenaemia in a newborn infant due to a novel mutation in the fibrinogen Aa gene. Br J Haematol 2002;119:282-3.
15. Neerman-Arbez M, Vu D, Abu-Libdeh B, Bouchardy I, Morris MA. Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family. Blood 2003;101:3492-4.
16. Spena S, Asselta R, Duga S, Malcovati M, Peyvandi F, Mannucci PM, et al. Congenital afibrinogenemia: intracellular retention of fibrinogen due to a novel W437G mutation in the fibrinogen Bb-chain gene. Biochim Biophys Acta 2003;1639:87-94.
17. Vu D, Bolton-Maggs PH, Parr JR, Morris MA, de Moerioose P, Neerman-Arbez M. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion. Blood 2003;102:4413-15.
18. Watanabe K, Shibuya A, Ishii E, Kurihara M, Inoue S, Ono M, et al. Identification of simultaneous mutation of fibrinogen a chain and protein C genes in a Japanese kindred. Br J Haematol 2003;120:101-8.
19. Asselta R, Duga S, Spena S, Peyvandi F, Castaman G, Malcovati M, et al. Missense or splicing mutation? The case of a fibrinogen Bb-chain mutation causing severe hypofibrinogenemia. Blood 2004;103:3051-4.
20. Neerman-Arbez M, Germanos-Haddad M, Tzanidakis K, Vu D, Deutsch S, David A, et al. Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells. Blood 2004;104:3618-23.
21. Spena S, Duga S, Asselta R, Peyvandi F, Mahasandana C, Malcovati M, et al. Congenital afibrinogenaemia caused by uniparental isodisomy of chromosome 4 containing a novel 15-kb deletion involving fibrinogen Aa-chain gene. Eur J Hum Genet 2004;12:891-8.
22. Wu S, Wang Z, Dong N, Bai X, Ruan C. A novel nonsense mutation in the FGA gene in a Chinese family with congenital afibrinogenaemia. Blood Coagul Fibrinolysis 2005;16:221-6.
23. Xu XC, Zhou RF, Wu JS, Fang Y, Wang XF, Zhai ZM, et al. Fibrinogen b chain gene mutation contributes to one congenital afibrinogenemia. Zhonghua Xue Ye Xue Za Zhi 2005;26:137-9.
24. Brennan SO, Fellowes AP, George PM. Molecular mechanisms of hypo- and afibrinogenemia. Ann N Y Acad Sci 2001;936:91-100.
25. Hanss M, Biot F. A database for human fibrinoeen variants. Ann N Y Acad Sci 2001;936:89-90. http://www.geht.org/databaseang/fibrinogen.
26. Duga S, Asselta R, Santagostino E, Zeinali S, Simonic T, Malcovati M, et al. Missense mutations in the human b fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood 2000;95:1336-41.
27. Maghzal GJ, Brennan SO, Fellowes AP, Spearing R, George PM. Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bb255 Arg→His (Fibrinogen Merivale). Biochim Biophys Acta 2003;1645:146-
28. Brennan SO, Wyatt JM, May S, De Caigney S, George PM. Hypofibrinogenemia due to novel 316 Asp→Tyr substitution in the fibrinogen Bb chain. Thromb Haemost 2001;85:450-3.
29. Cattaneo M, Bettega D, Lombardi R, Lecchi A, Mannucci PM. Sustained correction of the bleeding time in an afibrinogenaemic patient after infusion of fresh frozen plasma. Br J Haematol 1992;82:388-90.
30. Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with Bb cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990;265:6389-93.
31. Roy SN, Procyk R, Kudryk BJ, Redman CM. Assembly and secretion of recombinant human fibrinogen. J Biol Chem 1991;266:4758-63.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; 1970;227:680.
33. Duga S, Braidotti P, Asselta R, Maggioni M, Santagostino E, Peliegrini C, et al. Liver histology of an afibrinogenemic patient with the Bb-L353R mutation showing no evidence of hepatic endoplasmic reticulum storage disease (ERSD); comparative study in COS-1 cells of the intracellular processing of the Bb-L353R fibrinogen vs. the ERSD-associated g-G284R mutant. J Thromb Haemost 2005; 3:724-32.
34. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modelling. Electrophoresis 1997;18:2714-23.
35. Faye L, Sturm A, Bollini R, Vitale A, Chrispeels MJ. The position of the oligosaccharide side-chains of phytohemagglutinin and their accessibility to glycosidases determines their subsequent processing in the Golgi. Eur J Biochem 1986;158:655-61.
36. Peyvandi F, Mannucci FM. Rare coagulation disorders. Thromb Haemost 1999;82:1207-14.
37. Hanss M, Ffrench F, Vinciguerra C, Bertrand MA, de Mazancourt P. Four cases of hypofibrinogenemia associated with four novel mutations. J Thromb Haemost 2005;3:2347-9.
38. Vu D, Di Sanza C, Caille D, de Moerloose P, Scheib H, Meda P, et al. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia. Hum Mol Genet 2005;14:3271-80.
39. Townsend RR, Hilliker E, Li YT, Laine RA, Bell WR, Lee YC. Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides. J Biol Chem 1982;257:9704-10.
40. Callea F, Brisigotti M, Fabbretti G, Bonino F, Desmet VJ. Hepatic endoplasmic reticulum storage diseases. Liver 1992;12:357-62.
41. Brennan SO, Wyatt J, Medicina D, Callea F, George PM. Fibrinogen Brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a g284 Gly→Arg mutation. Am J Pathol 2000;157:189-96.
42. Brennan SO, Maghzal G, Shneider BL, Gordon R, Magid MS, George PM. Novel fibrinogen g375 Arg→Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology 2002;36:652-8.